Psychiatr Serv 50:1351-1353, October 1999
© 1999 American Psychiatric Association
Modeling the Pharmacoeconomic Cost of Three Selective Serotonin Reuptake Inhibitors
H. George Nurnberg, M.D.,
Paula L. Hensley, M.D.,
Peter M. Thompson, M.D., M.S. and
Susan S. Paine, M.P.H.
The authors present a method for modeling cost data on three selective serotonin reuptake inhibitors (SSRIs)—fluoxetine, paroxetine, and sertraline—from a large clinical outcomes study in a university-affiliated mental health center. Using data from 2,779 patients, average drug cost per day was calculated based on the percentage of patients on each daily dose of each medication. Given no overall significant difference between the SSRIs in effectiveness, the actual average cost per day determined by dose distribution was $1.79 for fluoxetine, $1.41 for paroxetine, and $1.21 for sertraline (using halved 100 mg tablets). The results suggest that cost can serve as one measure to help guide choice of medications.
This article has been cited by other articles:
|
|
|
|
 
C. B. Baker, M. T. Johnsrud, M. L. Crismon, R. A. Rosenheck, and S. W. Woods
Quantitative analysis of sponsorship bias in economic studies of antidepressants
The British Journal of Psychiatry,
December 1, 2003;
183(6):
498 - 506.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Baker
Engaging Community Mental Health Stakeholders in Pharmacy Cost Management
Psychiatr Serv,
May 1, 2001;
52(5):
650 - 653.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1999
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
